Top Markets
Coin of the day
Alimera Sciences, Inc. Alimera Sciences, Inc.

Alimera Sciences, Inc.

ALIM
Classifica tra le azioni #26666
Alimera Sciences, Inc. is a pharmaceutical company focused on developing and... Alimera Sciences, Inc. is a pharmaceutical company focused on developing and commercializing ophthalmic treatments globally, including in the United States. Its primary offering, ILUVIEN, is an intravitreal implant used to manage diabetic macular edema (DME), a severe retinal disease in individuals with diabetes that can lead to profound vision loss and blindness. Additionally, ILUVIEN helps prevent relapses of recurrent non-infectious uveitis affecting the posterior segment of the eye. The company distributes its products directly and through distributors to various healthcare entities such as physician offices, pharmacies, and hospitals. Alimera also maintains a collaboration with EyePoint Pharmaceuticals US, Inc. focused on developing and marketing insert technology. This technology is designed to deliver corticosteroids to the back of the eye for treating and preventing various human eye diseases, including diabetic macular edema. Founded in 2003, Alimera Sciences is headquartered in Alpharetta, Georgia.
Prezzo delle azioni
$5.54
Ultima sincronizzazione: 2024-09-18
Capitalizzazione di mercato
$38.76M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia Alimera Sciences, Inc. (ALIM)

Categoria

EPS per Alimera Sciences, Inc. (ALIM)
EPS al June 2024 TTM: $-0.28
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Alimera Sciences, Inc., l’EPS attuale della società (TTM) è $-0.28. Alla fine del 2022, la società aveva un EPS di $-2.59 un aumento rispetto a rispetto a quello del 2021, che era di $-0.66.
Storico EPS per Alimera Sciences, Inc. da 2006 a 2026
EPS alla fine di ogni anno
Anno EPS Cambia
2026 (TTM) $-0.28 -64.56%
2023 $-0.79 -69.50%
2022 $-2.59 292.42%
2021 $-0.66 -36.54%
2020 $-1.04 -52.51%
2019 $-2.19 -158.40%
2018 $3.75 -176.06%
2017 $-4.93 -47.66%
2016 $-9.42 -8.90%
2015 $-10.34 -22.43%
2014 $-13.33 -45.14%
2013 $-24.30 158.24%
2012 $-9.41 -12.63%
2011 $-10.77 61.95%
2010 $-6.65 -98.48%
2009 $-437.12 -23.24%
2008 $-569.46 977.30%
2007 $-52.86 -56.02%
2006 $-120.18 0.00%
EPS per aziende simili o concorrenti